Vladimir S. Rogovskii
Moscow, MOW 117513, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Anti-Inflammatory Properties of Curcumin as Add-On Therapy in Patients with MS-Prospective, Comparative, Randomized, Pilot Study.
Journal: Pharmaceutics
Published: February 24, 2026
Urolithin A increases the natural killer activity of PBMCs in patients with prostate cancer.
Journal: Frontiers in pharmacology
Published: September 28, 2024
Tumor-produced immune regulatory factors as a therapeutic target in cancer treatment.
Journal: Frontiers in immunology
Published: April 12, 2024
Cancer and Autoimmune Diseases as Two Sides of Chronic Inflammation and the Method of Therapy.
Journal: Current cancer drug targets
Published: September 15, 2023
Microbiota markers level in the blood and cerebrospinal fluid of patients with different types of multiple sclerosis and radiologically isolated syndrome
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 10, 2023
Evaluation of the structure of the human microbiome in multiple sclerosis by the concentrations of microbial markers in the blood.
Journal: Klinicheskaia laboratornaia diagnostika
Published: October 31, 2022
Prospects for the use of polyphenols in multiple sclerosis
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: August 01, 2022
The role of macrophages in the development of neuroinflammation in multiple sclerosis
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: May 25, 2022
The Therapeutic Potential of Urolithin A for Cancer Treatment and Prevention.
Journal: Current cancer drug targets
Published: February 18, 2022
The Dual Role of the β2-Adrenoreceptor in the Modulation of IL-17 and IFN-γ Production by T Cells in Multiple Sclerosis.
Journal: International journal of molecular sciences
Published: November 29, 2021
Polyphenols as the Potential Disease-modifying Therapy in Cancer.
Journal: Anti-cancer agents in medicinal chemistry
Published: October 28, 2021
The Role of D2-like Dopaminergic Receptor in Dopamine-mediated Modulation of Th17-cells in Multiple Sclerosis.
Journal: Current neuropharmacology
Published: June 06, 2021
Last Updated: 09/26/2026